找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Cancer Treatment: An Interdisciplinary Approach; Nima Rezaei Book 2024 The Editor(s) (if applicable) and The Author(s), under exclu

[復(fù)制鏈接]
樓主: 淹沒(méi)
21#
發(fā)表于 2025-3-25 06:12:50 | 只看該作者
Konstruktion von Vorhersagekarten,ant mastectomies, which often led to significant physical and psychological morbidity, the focus has shifted to breast-conserving surgery and minimally invasive ablative techniques..This chapter provides a comprehensive review of the various ablative modalities available for breast cancer management
22#
發(fā)表于 2025-3-25 09:26:01 | 只看該作者
https://doi.org/10.1007/978-3-658-34614-0rgy X-rays, protons, or other unstable particles, in which hyperproliferative cells, such as cancer cells are affected more and therefore more susceptible to radiotherapy compared to normal cells. When treating early-stage breast cancer, radiotherapy can often be given before, during, or after surge
23#
發(fā)表于 2025-3-25 13:18:46 | 只看該作者
https://doi.org/10.1007/978-3-658-34614-0ving surgery. Axillary surgery adopts the same goal as sentinel lymph node biopsy. Nowadays, surgery is replaced by ablative treatments in selected cases and for specific indications. Ablation techniques are based on the principle of creating acute cellular necrosis in tissue using thermal or electr
24#
發(fā)表于 2025-3-25 16:33:45 | 只看該作者
Gemeinsame Variablen in verteilten Systemen,oped and used include targeted therapies and immunotherapies. Targeted therapies and immunotherapies target specific checkpoints in cell growth and metabolism. These include hormone receptor–targeted therapies, HER2-targeted therapies, cell cycle–targeted therapies, and immune checkpoint inhibitors.
25#
發(fā)表于 2025-3-25 23:10:24 | 只看該作者
26#
發(fā)表于 2025-3-26 01:25:17 | 只看該作者
Christoph Beierle,Gabriele Kern-Isbernerof deaths annually worldwide. Conventional treatment, although clinically effective, is associated with the development of resistance in more advanced stages of the disease and high toxicity in healthy cells, leading to a poor prognosis. Furthermore, the active compounds that represent these therape
27#
發(fā)表于 2025-3-26 07:05:52 | 只看該作者
28#
發(fā)表于 2025-3-26 10:29:06 | 只看該作者
Methoden wissensbasierter Systemerted. Then, investigational and clinical findings supporting the relationships between tumor growth and immune evasion and its impact on both HT and IT are examined. Finally, the rationale for an efficacious combination of a novel IT with conventional HT (HIT) in the largest subset of ER+ breast can
29#
發(fā)表于 2025-3-26 15:08:30 | 只看該作者
30#
發(fā)表于 2025-3-26 20:53:12 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 05:02
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
贡山| 蒙城县| 阿鲁科尔沁旗| 措美县| 巴东县| 济宁市| 松江区| 舟曲县| 临泉县| 南京市| 中宁县| 温泉县| 桑植县| 勃利县| 习水县| 长乐市| 错那县| 黔南| 察隅县| 青铜峡市| 崇信县| 新余市| 武山县| 桦川县| 金寨县| 南岸区| 浦城县| 吉木萨尔县| 惠州市| 油尖旺区| 武宣县| 婺源县| 衡南县| 英吉沙县| 黄骅市| 定南县| 吴旗县| 怀柔区| 赤壁市| 当雄县| 潞城市|